Abstract:The controlled oligomerization of signaling proteins is an essential feature of many inflammatory signaling pathways. An example is IL-1 receptor signaling, which relies on the oligomerization of the Death Domain (DD)-containing proteins MyD88 and IRAK family kinases. This process leads to the assembly of the Myddosome signaling complex, and disrupting assembly holds potential for anti-inflammatory treatments. However, IRAKs’ signaling activity is also regulated by auto-/trans-phosphorylation, and it is unclear if these processes operate at or downstream of Myddosome assembly. Here, we find that the initial stage of Myddosome assembly is solely controlled by MyD88:IRAK4 DD interactions. In later stages, IRAK4 auto-phosphorylation serves as a switch, regulating IRAK1/2/3 incorporation and DD oligomerization. Small molecule inhibitors of IRAK4 kinase activity block this later stage of assembly, explaining how they dampen inflammatory signaling. Our data reveals IRAK4 auto-phosphorylation as an energy-dependent switch activating the heterotypic assembly of IRAKs’ DDs and downstream inflammatory IL-1 signaling. This highlights how a signaling cascade integrates phosphorylation and protein oligomerization steps.

What problem does this paper attempt to address?

The problem this paper attempts to address is: the specific role of IRAK4 autophosphorylation in inflammatory signaling and its impact on the oligomerization of IRAK family proteins. ### Background and Issues 1. **Importance of Inflammatory Signaling**: - Inflammatory signaling is crucial for innate immune responses, but its dysregulation can lead to inflammatory diseases. - IL-1 receptor (IL-1R) signaling is a key part of this process. 2. **Role of the Myddosome Complex**: - The Myddosome is an oligomeric immune complex composed of MyD88 and IRAK family proteins, involved in IL-1R signaling. - The formation of the Myddosome requires the co-assembly of MyD88 with IRAK4 and IRAK1, IRAK2, or IRAK3. 3. **IRAK4 Autophosphorylation**: - IRAK4 has the ability to autophosphorylate and phosphorylate other IRAK family members. - The kinase activity of IRAK4 is crucial for downstream signaling, but the specific timing of its role in the signaling pathway is not yet clear. ### Research Objectives - **Clarify the Role of IRAK4 Autophosphorylation in Myddosome Assembly**: - Investigate whether IRAK4 autophosphorylation is an independent stage of Myddosome assembly. - Explore how IRAK4 autophosphorylation regulates the recruitment and oligomerization of IRAK1, IRAK2, and IRAK3. - **Reveal the Molecular Mechanism of IRAK4 Autophosphorylation**: - Analyze how IRAK4 autophosphorylation acts as an energy-dependent switch controlling the final stages of Myddosome assembly. - Investigate whether this mechanism is universally applicable to the recruitment of IRAK1, IRAK2, and IRAK3. ### Key Findings - **IRAK4 Autophosphorylation is an Independent Stage of Myddosome Assembly**: - IRAK4 autophosphorylation occurs after the co-assembly of MyD88 and IRAK4 but before the recruitment of IRAK1. - Inhibiting IRAK4 kinase activity does not affect the initial co-assembly of MyD88 and IRAK4 but reduces the stable recruitment of IRAK1. - **IRAK4 Autophosphorylation Regulates the Recruitment of IRAK1, IRAK2, and IRAK3**: - IRAK4 autophosphorylation promotes the recruitment and oligomerization of these proteins by forming heterodimers with the kinase domains of IRAK1, IRAK2, and IRAK3. - This mechanism applies not only to IRAK1 but also to IRAK2 and IRAK3. ### Conclusion - **IRAK4 Autophosphorylation as a Key Regulatory Switch**: - IRAK4 autophosphorylation is an energy-dependent intermediate stage of Myddosome assembly, controlling the final recruitment and oligomerization of IRAK1, IRAK2, and IRAK3. - This mechanism explains how IRAK4 kinase inhibitors can suppress inflammatory signaling by interfering with this process. Through these studies, the authors reveal the important role of IRAK4 autophosphorylation in inflammatory signaling, providing a theoretical basis for the development of anti-inflammatory drugs targeting IRAK4.

IRAK4 autophosphorylation controls inflammatory signaling by activating IRAK oligomerization

Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop.

The research advance of IRAK1 in immune regulation

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

Selective IRAK4 degradation, not kinase inhibition, blocks TLR-activated NF-Kb and p38 Signaling leading to broad cytokine inhibition

Phosphatase SHP-1 Promotes TLR- and RIG-I-activated Production of Type I Interferon by Inhibiting the Kinase IRAK1

Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.

The IRAK-M death domain: a tale of three surfaces

Interleukin-1 (IL-1) Receptor-Associated Kinase-Dependent IL-1-Induced Signaling Complexes Phosphorylate TAK1 and TAB2 at the Plasma Membrane and Activate TAK1 in the Cytosol

IRAK4 Kinase Activity is Redundant for Interleukin-1 (IL-1) Receptor-associated Kinase Phosphorylation and IL-1 Responsiveness

The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

Interleukin-1 receptor-associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll-like receptors 4 and 7/8 in murine and human lungs

Discovery of 5-Aryl-2,4-diaminopyrimidine Compounds as Potent and Selective IRAK4 Inhibitors.

IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases

IRAK-mediated Translocation of TRAF6 and TAB2 in the Interleukin-1-induced Activation of NFκB

IRAK-dependent Phosphorylation of Stat1 on Serine 727 in Response to Interleukin-1 and Effects on Gene Expression.

Β-Trcp-mediated IRAK1 Degradation Releases TAK1-TRAF6 from the Membrane to the Cytosol for TAK1-Dependent NF-κB Activation

Recent Advances in IRAK1: Pharmacological and Therapeutic Aspects

Non-Lyn Src Family Kinases Activate SIRPα-SHP-1 to Inhibit PI3K-Akt2 and Dampen Proinflammatory Macrophage Polarization

IRAK2 Directs Stimulus-Dependent Nuclear Export of Inflammatory Mrnas.